搜尋結果
Trustbusters target poor man’s John D. Rockefeller
Reuters· 2 小時前Taking on industrialist John D. Rockefeller and breaking up his Standard Oil helped shape U.S. ...
Linde's guidance leaves investors wanting more. We're saying thanks to the sellers
CNBC· 3 小時前Shares of Linde fell on Thursday after the industrial gas giant reported mixed first-quarter ...
Weak US productivity could threaten Fed's 'soft landing' hopes
Reuters· 4 小時前Weaker U.S. productivity gains in the first quarter may challenge the Federal Reserve's ...
Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply
Bloomberg· 5 小時前Have a confidential tip for our reporters? Shortages have left patients already on the medicati ...
Wegovy, Mounjaro prices cut as British pharmacies compete for weight-loss patients
Reuters· 5 小時前Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain ...
‘Evil Does Not Exist’ Review: A Languorous Look at Rural Japan
The Wall Street Journal· 5 小時前Rural Japan seems like an oxymoron, given that it is one of the most urbanized countries on ...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 6 小時前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
Fed Hold Rates for Sixth Time, Novo Nordisk Quadruples Numbers | Bloomberg Markets Today 05/02
Bloomberg· 7 小時前The yen weakens after a surge of over 3% in New York trading, fueling speculation of intervention. Plus another big day ...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters· 8 小時前, opens new tab missed Wall Street estimates for quarterly profit on Thursday, hurt by softer ...
Khosla, VCs Plow $100 Million Into Blood Test Startup Using AI
Bloomberg· 9 小時前Karius’ technology is already being used to test patients’ blood for infections.